FGFR1 and lymphoma: IMB-R1 staining was significantly stronger in cancer cells in the breast, lung, lymphoma, esophagus, bladder and ovary tissues as well as in melanoma cells compared to adjacent normal tissue, suggesting FGFR1 expression is increased in these tumors (Fig. 7b).